Barroso-Sousa, Romualdo, Svitlana Tyekucheva, Pedro Exman, Renato Umeton, F. Stephen Hodi, Eric P. Winer, Nancy U Lin, and Sara M. Tolaney. “TUMOR MUTATIONAL BURDEN (TMB) IS A POTENTIAL PREDICTOR OF RESPONSE TO IMMUNE CHECKPOINT INHIBITORS (ICI) IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC)”. Mastology 29, no. 3 (September 29, 2019): 5. Accessed November 12, 2024. https://revistamastology.emnuvens.com.br/revista/article/view/728.